GENOCEA BIOSCIENCES, INC. 4
4 · GENOCEA BIOSCIENCES, INC. · Filed Nov 9, 2016
Insider Transaction Report
Form 4
HETHERINGTON SETH V
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2016-11-09$2.02/sh+5,000$10,100→ 26,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-11-09$2.02/sh−5,000$10,100→ 61,955 totalExercise: $2.02Exp: 2021-02-17→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The option was granted on 2/17/2011 and the vesting schedule was completed in February 2015.